EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical

Hayrettin Eroglu iD, Arif Kürsad Ayan, Ayse Yenilmez

Molecules · 2026

DOI: 10.3390/molecules31040654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Hayrettin Eroglu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Faculty of Engineering and Architecture, Erzurum Technical University, 25110 Erzurum, Türkiye. Hauptthemen laut MEDLINE: Nanoparticles, Technetium, Radiopharmaceuticals, Lipids. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid lipid nanoparticles (SLNs) are submicron colloidal systems widely investigated as drug carriers; however, their intrinsic biodistribution properties are also critical when SLNs are considered for diagnostic imaging. In the present proof-of-concept study, drug-free SLNs were evaluated exclusively as a radiolabeled imaging agent rather than as a drug delivery system. SLNs were radiolabeled with Technetium-99m (99mTc), and their in vivo biodistribution was investigated using gamma camera imaging, ex vivo organ counting, and confocal microscopy. SLNs were prepared by a microemulsion–low-temperature solidification method and characterized by dynamic light scattering (DLS), scanning electron microscopy (SEM), and differential scanning calorimetry (DSC). Radiolabeling efficiency was determined by instant thin-layer chromatography (ITLC) and exceeded 95%. Following intravenous administration in a rabbit model, dynamic scintigraphic imaging demonstrated predominant uptake in the liver and spleen. These findings were quantitatively confirmed by ex vivo biodistribution analysis at 4 h post-injection and qualitatively supported by confocal microscopy of liver and spleen tissues. The results indicate that 99mTc-labeled SLNs behave as RES-targeting radiocolloids and may serve as potential agents for liver–spleen scintigraphy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesTechnetiumRadiopharmaceuticalsLipidsAnimalsTissue DistributionRabbitsRadionuclide ImagingLiverSpleenLiposomes

Stichwörter der Autor:innen

Tc-99mbiodistributiondrug deliveryscintigraphysolid lipid nanoparticle

Substanzen

TechnetiumRadiopharmaceuticalsLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Chemical Engineering, Faculty of Engineering and Architecture, Erzurum Technical University, 25110 Erzurum, Türkiye.
  • Department of Nuclear Medicine, Samsun Medicana Hospital, 55100 Samsun, Türkiye.
  • Department of Mathematics and Science Education, Faculty of Education, Van Yüzüncü Yıl University, 65080 Van, Türkiye.

ORCID-Profile: Hayrettin Eroglu

Zitieren

APA

Eroglu, H., Ayan, A. K., & Yenilmez, A. (2026). Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical. Molecules. https://doi.org/10.3390/molecules31040654

Vancouver

Eroglu H, Ayan AK, Yenilmez A. Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical. Molecules. 2026. doi:10.3390/molecules31040654

BibTeX
@article{Eroglu2026,
  author = {Eroglu, Hayrettin and Ayan, Arif Kürsad and Yenilmez, Ayse},
  title = {Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31040654}
}
Kostenlos starten →